BACKGROUND
Leishmaniasis is a global public health problem without adequate treatment options, hence requiring research on new drug development.
OBJECTIVE
Our main objective was the evaluation of a kaurenic acid (ent-kaur-16-in-19-oico), isolated from the Venezuelan plant Wedelia trilobata